Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DaIEI: DMARDs for arthritis associated with inborn errors of immunity
jRCTs031240414Recruiting
- Start
- Oct 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial in arthritis associated with inborn errors of immunity and Immunogenetic disorder. Primary endpoint: Clinical Disease Activity Index at 36 weeks. Started Oct 2025; status: recruiting.
02
Conditions
arthritis associated with inborn errors of immunityImmunogenetic disorder
Beyond the preview
Go deeper on jRCTs031240414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240414.